Over the last several decades, the US Food and Drug Administration’s (FDA) accelerated approval program has largely been working as it was designed to, with about half the products using the pathway ...

For driven first-year RIT students like Lauren Reger and Palak Wadhwa, getting a jump on studying and conducting research, all while steadily moving on the path toward a graduate degree, was an ...

Accelerated approval is an important regulatory pathway that provides early access to treatments for patients with serious and life-threatening conditions. It is granted based on substantial evidence ...

Rochester Institute of Technology’s College of Liberal Arts and University of Rochester’s Warner School of Education have established new 3+2 and 4+1 admissions agreements, providing RIT undergraduate ...

The Food and Drug Administration’s accelerated approval program aims to speed “approval of drugs that treat serious conditions, and fill an unmet medical need based on a surrogate endpoint” of overall ...

On Dec. 6, 2024, the FDA released draft guidance, marking a significant development in the regulatory framework for therapies approved under the Accelerated Approval Program. The 22-page guidance ...

MISSOULA, Mont. — Highlands College is offering a new accelerated pathway to an associates of science degree in automotive technology. The program will let high school seniors earn their associates ...

One hallmark of the FDA's accelerated approval pathway is the requirement that medicines prove their benefits in confirmatory trials. Now, new research shows that many cancer drugs approved under the ...

Hope College students majoring in communication can take a fast track to a master’s degree thanks to a new partnership between the college and Western Michigan University. The college and university ...

Accelerated approvals for cancer drugs is a good idea in theory. This US Food and Drug Administration (FDA) pathway allows promising new cancer agents to reach the market, and patients, sooner. But ...

Originally conceived to address one of our most daunting public health challenges—the AIDS epidemic—and reinforced for use in cancer and rare diseases, the Food and Drug Administration’s (FDA’s) ...